Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 916.84 $ 11.84 (1.31 %)    

Wednesday, 17-Jul-2024 12:56:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 483.07 $ -5.58 (-1.14 %)
DIA $ 412.03 $ 3.02 (0.74 %)
SPY $ 557.56 $ -1.34 (-0.24 %)
TLT $ 94.26 $ 0.35 (0.37 %)
GLD $ 227.20 $ -1.59 (-0.69 %)
$ 941.6
$ 905.00
$ 0.00 x 0
$ 0.00 x 0
$ 905.00 - $ 924.40
$ 439.97 - $ 966.10
2,111,799
na
851.02B
$ 0.57
$ 138.64
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pfizer-and-roche-advance-on-their-weight-loss-drug-journeys
Pfizer And Roche Advance On Their Weight L...
07/17/2024 14:48:52

After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, P...

obesity-drugs-focused-stocks-tumble-on-wednesday---whats-going-on-with-eli-lilly-novo-nordisk-viking-therapeutics-structure-therapeutics
Obesity-Drugs Focused Stocks Tumble On Wed...
07/17/2024 14:47:40

Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996...

Core News & Articles
Benzinga Market Summary: Chip Stocks Fall ...
07/17/2024 13:33:51

jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there
Jim Cramer Says Don't Sell Match Group: 'Y...
07/17/2024 12:55:11

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run c...

senate-to-review-novo-nordisks-levemir-insulin-discontinuation
Senate To Review Novo Nordisk's Levemir In...
07/16/2024 17:49:39

Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns...

eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking
Eli Lilly and Co's Options: A Look at What...
07/16/2024 14:31:21

this-analyst-sees-potential-downside-in-eli-lilly-adjusts-model-for-acquired-iprd-charges
This Analyst Sees Potential Downside In El...
07/15/2024 17:13:12

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's...

eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking
Eli Lilly and Co's Options: A Look at What...
07/15/2024 13:47:18

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/15/2024 13:08:21

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

with-oral-anti-obesity-candidate-development-pfizer-seeks-relevant-and-competitive-presence---goldman-sachs
With Oral Anti-Obesity Candidate Developme...
07/12/2024 16:26:42

Pfizer has selected its preferred once-daily modified release formulation for danuglipron, an oral GLP-1 receptor agonist, with...

in-depth-analysis-eli-lilly-and-co-versus-competitors-in-pharmaceuticals-industry
In-Depth Analysis: Eli Lilly and Co Versus...
07/12/2024 15:00:27

using-ozempic-zepbound-or-other-weight-loss-drugs-inform-doctors-before-anesthesia-or-surgery-european-medicines-agency-issues-advisory
Using Ozempic, Zepbound Or Other Weight Lo...
07/12/2024 14:11:48

EMA advises patients on GLP-1 weight-loss drugs like Wegovy to inform their doctors before surgery due to potential respiratory...

novo-nordisks-miracle-weight-loss-drug-ozempic-linked-to-48-lower-risk-of-dementia-study-finds
Novo Nordisk's 'Miracle' Weight Loss Drug ...
07/12/2024 09:19:51

Novo Nordisk has found that its diabetes drug, Ozempic, is linked to a significant reduction in the risk of dementia and other ...

eli-lilly-novo-nordisk-shares-dip-as-pfizer-ramps-up-diabetes-drug-competition
Eli Lilly, Novo Nordisk Shares Dip As Pfiz...
07/11/2024 20:10:16

Shares of Eli Lilly and Co (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are facing declines Thursday, maybe influenced by compe...

bernie-sanders-targets-high-prices-of-ozempic-and-wegovy-in-us
Bernie Sanders Targets High Prices of Ozem...
07/11/2024 17:47:17

Senator Bernie Sanders is pushing Novo Nordisk to lower U.S. prices for weight-loss drugs Ozempic and Wegovy, as part of a broa...

berenberg-maintains-buy-on-eli-lilly-and-co-raises-price-target-to-1000
Berenberg Maintains Buy on Eli Lilly and C...
07/11/2024 16:42:06

Berenberg analyst Kerry Holford maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $850 to $1...

jp-morgan-maintains-overweight-on-eli-lilly-and-co-raises-price-target-to-1000
JP Morgan Maintains Overweight on Eli Lill...
07/11/2024 14:56:56

JP Morgan analyst Chris Schott maintains Eli Lilly and Co (NYSE:LLY) with a Overweight and raises the price target from $900...

jim-cramer-identifies-eight-companies-eyeing-trillion-dollar-club--elon-musks-tesla-eli-lilly-top-contenders
Jim Cramer Identifies Eight Companies Eyei...
07/11/2024 07:00:11

Jim Cramer has identified eight companies that could potentially reach a market cap of $1 trillion, including Elon Musk's T...

barclays-maintains-overweight-on-eli-lilly-and-co-raises-price-target-to-1025
Barclays Maintains Overweight on Eli Lilly...
07/10/2024 23:29:55

Barclays analyst Carter Gould maintains Eli Lilly and Co (NYSE:LLY) with a Overweight and raises the price target from $913 ...

eli-lilly-announces-cfo-change
Eli Lilly Announces CFO Change
07/10/2024 19:35:39

Shares of Eli Lilly And Company (NYSE: LLY) are moving higher on Wednesday. Here's what you need to know.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)